Dr Omer Yusaf, MD | |
8201 E Riverside Blvd, Rockford, IL 61114-2300 | |
(815) 971-4066 | |
(815) 971-9299 |
Full Name | Dr Omer Yusaf |
---|---|
Gender | Male |
Speciality | Hospitalist |
Experience | 28 Years |
Location | 8201 E Riverside Blvd, Rockford, Illinois |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1669585956 | NPI | - | NPPES |
1669585956 | Medicaid | WI | |
036121271 | Medicaid | IL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | 036121271 (Illinois) | Secondary |
207R00000X | Internal Medicine | 036121271 (Illinois) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Presence Saint Joseph Medical Center | Joliet, IL | Hospital |
Ottawa Regional Hospital Dba Osf Saint Elizabeth Mdl Ctr | Ottawa, IL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Presence Healthcare Services | 2860396769 | 401 |
24 On Physicians Pc | 5698688141 | 250 |
News Archive
NeuroDerm, Ltd. announced today that enrollment of patients is ongoing in its second Phase II clinical trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease. ND0612 is a proprietary levodopa/carbidopa liquid formulation under development for continuous subcutaneous administration through a patch pump. It is designed to provide steady levodopa blood levels for the treatment of Parkinson's disease.
A new study shows that in 2008-2009 more than 9,300 patients died of sepsis, a condition resulting from the body's response to severe infection, in Canadian hospitals outside Quebec.
23andMe, the leading personal genetics company, is celebrating National DNA Day by taking an in-depth look at what Americans know about their DNA and how genetics play a role in our everyday lives. The survey found that 91 percent of Americans know that their genetic information has important utility in managing their health.
As diagnostic imaging and radiation treatment technologies both become more capable and precise, physicians using them face an increasingly difficult task: how to transfer information from the diagnostic systems to the treatment planning systems.
For the second time, The Leapfrog Group has named UC San Diego Health System to its annual list of Top Hospitals. Awarded to hospitals nationwide for demonstrating excellence in hospital safety and quality, the Leapfrog Top Hospital award is an elite distinction given to less than seven percent of all eligible hospitals. The awards were announced on December 2, in Washington, D.C.
› Verified 7 days ago
Entity Name | Rockford Health Physicians |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043242886 PECOS PAC ID: 2567374036 Enrollment ID: O20031103000584 |
News Archive
NeuroDerm, Ltd. announced today that enrollment of patients is ongoing in its second Phase II clinical trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease. ND0612 is a proprietary levodopa/carbidopa liquid formulation under development for continuous subcutaneous administration through a patch pump. It is designed to provide steady levodopa blood levels for the treatment of Parkinson's disease.
A new study shows that in 2008-2009 more than 9,300 patients died of sepsis, a condition resulting from the body's response to severe infection, in Canadian hospitals outside Quebec.
23andMe, the leading personal genetics company, is celebrating National DNA Day by taking an in-depth look at what Americans know about their DNA and how genetics play a role in our everyday lives. The survey found that 91 percent of Americans know that their genetic information has important utility in managing their health.
As diagnostic imaging and radiation treatment technologies both become more capable and precise, physicians using them face an increasingly difficult task: how to transfer information from the diagnostic systems to the treatment planning systems.
For the second time, The Leapfrog Group has named UC San Diego Health System to its annual list of Top Hospitals. Awarded to hospitals nationwide for demonstrating excellence in hospital safety and quality, the Leapfrog Top Hospital award is an elite distinction given to less than seven percent of all eligible hospitals. The awards were announced on December 2, in Washington, D.C.
› Verified 7 days ago
Entity Name | 24 On Physicians Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346480431 PECOS PAC ID: 5698688141 Enrollment ID: O20090609000389 |
News Archive
NeuroDerm, Ltd. announced today that enrollment of patients is ongoing in its second Phase II clinical trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease. ND0612 is a proprietary levodopa/carbidopa liquid formulation under development for continuous subcutaneous administration through a patch pump. It is designed to provide steady levodopa blood levels for the treatment of Parkinson's disease.
A new study shows that in 2008-2009 more than 9,300 patients died of sepsis, a condition resulting from the body's response to severe infection, in Canadian hospitals outside Quebec.
23andMe, the leading personal genetics company, is celebrating National DNA Day by taking an in-depth look at what Americans know about their DNA and how genetics play a role in our everyday lives. The survey found that 91 percent of Americans know that their genetic information has important utility in managing their health.
As diagnostic imaging and radiation treatment technologies both become more capable and precise, physicians using them face an increasingly difficult task: how to transfer information from the diagnostic systems to the treatment planning systems.
For the second time, The Leapfrog Group has named UC San Diego Health System to its annual list of Top Hospitals. Awarded to hospitals nationwide for demonstrating excellence in hospital safety and quality, the Leapfrog Top Hospital award is an elite distinction given to less than seven percent of all eligible hospitals. The awards were announced on December 2, in Washington, D.C.
› Verified 7 days ago
Entity Name | Carle Health Care Incorporated |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1154653947 PECOS PAC ID: 3577515774 Enrollment ID: O20100513000829 |
News Archive
NeuroDerm, Ltd. announced today that enrollment of patients is ongoing in its second Phase II clinical trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease. ND0612 is a proprietary levodopa/carbidopa liquid formulation under development for continuous subcutaneous administration through a patch pump. It is designed to provide steady levodopa blood levels for the treatment of Parkinson's disease.
A new study shows that in 2008-2009 more than 9,300 patients died of sepsis, a condition resulting from the body's response to severe infection, in Canadian hospitals outside Quebec.
23andMe, the leading personal genetics company, is celebrating National DNA Day by taking an in-depth look at what Americans know about their DNA and how genetics play a role in our everyday lives. The survey found that 91 percent of Americans know that their genetic information has important utility in managing their health.
As diagnostic imaging and radiation treatment technologies both become more capable and precise, physicians using them face an increasingly difficult task: how to transfer information from the diagnostic systems to the treatment planning systems.
For the second time, The Leapfrog Group has named UC San Diego Health System to its annual list of Top Hospitals. Awarded to hospitals nationwide for demonstrating excellence in hospital safety and quality, the Leapfrog Top Hospital award is an elite distinction given to less than seven percent of all eligible hospitals. The awards were announced on December 2, in Washington, D.C.
› Verified 7 days ago
Entity Name | Sound Physicians Of Illinois Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043598865 PECOS PAC ID: 1557533734 Enrollment ID: O20111012000272 |
News Archive
NeuroDerm, Ltd. announced today that enrollment of patients is ongoing in its second Phase II clinical trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease. ND0612 is a proprietary levodopa/carbidopa liquid formulation under development for continuous subcutaneous administration through a patch pump. It is designed to provide steady levodopa blood levels for the treatment of Parkinson's disease.
A new study shows that in 2008-2009 more than 9,300 patients died of sepsis, a condition resulting from the body's response to severe infection, in Canadian hospitals outside Quebec.
23andMe, the leading personal genetics company, is celebrating National DNA Day by taking an in-depth look at what Americans know about their DNA and how genetics play a role in our everyday lives. The survey found that 91 percent of Americans know that their genetic information has important utility in managing their health.
As diagnostic imaging and radiation treatment technologies both become more capable and precise, physicians using them face an increasingly difficult task: how to transfer information from the diagnostic systems to the treatment planning systems.
For the second time, The Leapfrog Group has named UC San Diego Health System to its annual list of Top Hospitals. Awarded to hospitals nationwide for demonstrating excellence in hospital safety and quality, the Leapfrog Top Hospital award is an elite distinction given to less than seven percent of all eligible hospitals. The awards were announced on December 2, in Washington, D.C.
› Verified 7 days ago
Entity Name | Cep America-illinois Hospitalists, Llp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1841613403 PECOS PAC ID: 3274765904 Enrollment ID: O20140411001788 |
News Archive
NeuroDerm, Ltd. announced today that enrollment of patients is ongoing in its second Phase II clinical trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease. ND0612 is a proprietary levodopa/carbidopa liquid formulation under development for continuous subcutaneous administration through a patch pump. It is designed to provide steady levodopa blood levels for the treatment of Parkinson's disease.
A new study shows that in 2008-2009 more than 9,300 patients died of sepsis, a condition resulting from the body's response to severe infection, in Canadian hospitals outside Quebec.
23andMe, the leading personal genetics company, is celebrating National DNA Day by taking an in-depth look at what Americans know about their DNA and how genetics play a role in our everyday lives. The survey found that 91 percent of Americans know that their genetic information has important utility in managing their health.
As diagnostic imaging and radiation treatment technologies both become more capable and precise, physicians using them face an increasingly difficult task: how to transfer information from the diagnostic systems to the treatment planning systems.
For the second time, The Leapfrog Group has named UC San Diego Health System to its annual list of Top Hospitals. Awarded to hospitals nationwide for demonstrating excellence in hospital safety and quality, the Leapfrog Top Hospital award is an elite distinction given to less than seven percent of all eligible hospitals. The awards were announced on December 2, in Washington, D.C.
› Verified 7 days ago
Entity Name | Presence Healthcare Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1356727127 PECOS PAC ID: 2860396769 Enrollment ID: O20150810001673 |
News Archive
NeuroDerm, Ltd. announced today that enrollment of patients is ongoing in its second Phase II clinical trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease. ND0612 is a proprietary levodopa/carbidopa liquid formulation under development for continuous subcutaneous administration through a patch pump. It is designed to provide steady levodopa blood levels for the treatment of Parkinson's disease.
A new study shows that in 2008-2009 more than 9,300 patients died of sepsis, a condition resulting from the body's response to severe infection, in Canadian hospitals outside Quebec.
23andMe, the leading personal genetics company, is celebrating National DNA Day by taking an in-depth look at what Americans know about their DNA and how genetics play a role in our everyday lives. The survey found that 91 percent of Americans know that their genetic information has important utility in managing their health.
As diagnostic imaging and radiation treatment technologies both become more capable and precise, physicians using them face an increasingly difficult task: how to transfer information from the diagnostic systems to the treatment planning systems.
For the second time, The Leapfrog Group has named UC San Diego Health System to its annual list of Top Hospitals. Awarded to hospitals nationwide for demonstrating excellence in hospital safety and quality, the Leapfrog Top Hospital award is an elite distinction given to less than seven percent of all eligible hospitals. The awards were announced on December 2, in Washington, D.C.
› Verified 7 days ago
Entity Name | Carle West Physician Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1467074138 PECOS PAC ID: 8921420308 Enrollment ID: O20200613000147 |
News Archive
NeuroDerm, Ltd. announced today that enrollment of patients is ongoing in its second Phase II clinical trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease. ND0612 is a proprietary levodopa/carbidopa liquid formulation under development for continuous subcutaneous administration through a patch pump. It is designed to provide steady levodopa blood levels for the treatment of Parkinson's disease.
A new study shows that in 2008-2009 more than 9,300 patients died of sepsis, a condition resulting from the body's response to severe infection, in Canadian hospitals outside Quebec.
23andMe, the leading personal genetics company, is celebrating National DNA Day by taking an in-depth look at what Americans know about their DNA and how genetics play a role in our everyday lives. The survey found that 91 percent of Americans know that their genetic information has important utility in managing their health.
As diagnostic imaging and radiation treatment technologies both become more capable and precise, physicians using them face an increasingly difficult task: how to transfer information from the diagnostic systems to the treatment planning systems.
For the second time, The Leapfrog Group has named UC San Diego Health System to its annual list of Top Hospitals. Awarded to hospitals nationwide for demonstrating excellence in hospital safety and quality, the Leapfrog Top Hospital award is an elite distinction given to less than seven percent of all eligible hospitals. The awards were announced on December 2, in Washington, D.C.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Omer Yusaf, MD 8201 E Riverside Blvd, Rockford, IL 61114-2300 Ph: (815) 971-4066 | Dr Omer Yusaf, MD 8201 E Riverside Blvd, Rockford, IL 61114-2300 Ph: (815) 971-4066 |
News Archive
NeuroDerm, Ltd. announced today that enrollment of patients is ongoing in its second Phase II clinical trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease. ND0612 is a proprietary levodopa/carbidopa liquid formulation under development for continuous subcutaneous administration through a patch pump. It is designed to provide steady levodopa blood levels for the treatment of Parkinson's disease.
A new study shows that in 2008-2009 more than 9,300 patients died of sepsis, a condition resulting from the body's response to severe infection, in Canadian hospitals outside Quebec.
23andMe, the leading personal genetics company, is celebrating National DNA Day by taking an in-depth look at what Americans know about their DNA and how genetics play a role in our everyday lives. The survey found that 91 percent of Americans know that their genetic information has important utility in managing their health.
As diagnostic imaging and radiation treatment technologies both become more capable and precise, physicians using them face an increasingly difficult task: how to transfer information from the diagnostic systems to the treatment planning systems.
For the second time, The Leapfrog Group has named UC San Diego Health System to its annual list of Top Hospitals. Awarded to hospitals nationwide for demonstrating excellence in hospital safety and quality, the Leapfrog Top Hospital award is an elite distinction given to less than seven percent of all eligible hospitals. The awards were announced on December 2, in Washington, D.C.
› Verified 7 days ago
Dr. Adekola Abioudun Ashaye, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1200 W State St, Rockford, IL 61102 Phone: 815-490-1600 Fax: 815-490-1881 | |
Prasad K. Kilaru, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2350 N Rockton Ave, Rockford, IL 61103 Phone: 815-971-2000 | |
David R. Mitchell, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 5970 Churchview Dr, Rockford, IL 61107 Phone: 815-971-2000 | |
Dr. Amrutha Mary George, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1253 N Alpine Rd, Rockford, IL 61107 Phone: 779-696-9201 | |
Rajyalaxmi Mullapudi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5666 E State St, Rockford, IL 61108 Phone: 815-226-2000 | |
Geoffrey Tsaras, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1340 Charles St Ste 404, Rockford, IL 61104 Phone: 779-696-1890 Fax: 779-696-2410 | |
Stephanie Birmingham, APN Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2400 N Rockton Ave, Rockford, IL 61103 Phone: 815-971-5000 |